Evidence map›Paper›PMID 25075529›Full record

ArticleIET systems biology2014

Knowledge discovery for pancreatic cancer using inductive logic programming.

Yushan Qiu, Kazuaki Shimada, Nobuyoshi Hiraoka, Kensei Maeshiro, Wai-Ki Ching, Kiyoko F Aoki-Kinoshita, Koh Furuta

Abstract read
In one paragraph

Article in IET systems biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yushan QiuAdvanced Modeling and Applied Computing Laboratory, Department of Mathematics, The University of Hong Kong, Pokfulam Road, Hong Kong, People's Republic of China. yushanqiu2526374@163.com.
Kazuaki ShimadaHepatobiliary and Pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan.
Nobuyoshi HiraokaPathology Division, National Cancer Center Research Institute, Tokyo, Japan.
Kensei MaeshiroDepartment of Surgery, Fukuoka University, Fukuoka, Japan.
Wai-Ki ChingAdvanced Modeling and Applied Computing Laboratory, Department of Mathematics, The University of Hong Kong, Pokfulam Road, Hong Kong, People's Republic of China.
Kiyoko F Aoki-KinoshitaDepartment of Bioinformatics, Faculty of Engineering, Soka University, Tokyo, Japan.
Koh FurutaDivision of Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pancreatic cancer is a devastating disease and predicting the status of the patients becomes an important and urgent issue. The authors explore the applicability of inductive logic programming (ILP) method in the disease and show that the accumulated clinical laboratory data can be used to predict disease characteristics, and this will contribute to the selection of therapeutic modalities of pancreatic cancer. The availability of a large amount of clinical laboratory data provides clues to aid in the knowledge discovery of diseases. In predicting the differentiation of tumour and the status of lymph node metastasis in pancreatic cancer, using the ILP model, three rules are developed that are consistent with descriptions in the literature. The rules that are identified are useful to detect the differentiation of tumour and the status of lymph node metastasis in pancreatic cancer and therefore contributed significantly to the decision of therapeutic strategies. In addition, the proposed method is compared with the other typical classification techniques and the results further confirm the superiority and merit of the proposed method.

Indexed as

Artificial IntelligenceDecision Support Systems, ClinicalLogistic ModelsBiomarkers, TumorComputer SimulationDecision Support TechniquesDiagnosis, Computer-AssistedHumansLymphatic MetastasisPancreatic NeoplasmsReproducibility of ResultsRisk AssessmentSensitivity and SpecificityBiomarkers, Tumor

Identifiers

PMID25075529
PMCPMC8687153

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.